Numerous investigators reported the prognostic significance of CD44 overexpression in ccRCC, which is the most common type of renal cancer, but the role of this marker in non-ccRCCs is still not fully understood [9,17,26,27,28,29]. The gene discussed is CD44; the disease is nonpapillary renal cell carcinoma.